JB Medical Ltd, The Old Brickworks, Little Cornard, Sudbury, UK.
Aliment Pharmacol Ther. 2012 Jan;35(2):222-37. doi: 10.1111/j.1365-2036.2011.04927.x. Epub 2011 Nov 24.
Previous reviews of bowel preparation for colonoscopy have given contradictory answers.
To provide a definitive insight, using PRISMA-compliant methodology.
A comprehensive literature review identified randomised controlled trials comparing bowel preparation regimens. Data for quality of bowel preparation were pooled in multiple meta-analyses exploring a range of inclusion criteria.
A total of 104 qualifying studies were identified, the majority of which involved comparisons of sodium phosphate (NaP) or polyethylene glycol (PEG). There was no significant difference demonstrated between NaP and PEG overall (OR = 0.82; 95% CI = 0.56-1.21; P = 0.36). Cumulative meta-analysis demonstrated that this conclusion has been qualitatively similar since the mid 1990s, with little quantitative change for the past 10 years. Amongst studies with previous day dosing in both study arms there was a significant advantage in favour of PEG (OR = 1.78; 95% CI = 1.13-2.81; P = 0.006). Studies focussing on results in the proximal colon also favoured PEG (OR = 2.36; 95% CI = 1.16-4.77; P = 0.012). PEG was also significantly more effective than non-NaP bowel preparation regimens (OR = 2.02; 95% CI = 1.08-3.78; P = 0.03). Other comparisons showed no significant difference between regimens.
Although there is no compelling evidence favouring either of the two most commonly used bowel preparation regimens, this may reflect shortcomings in study design. Where studies have ensured comparable dosage, or the clinically relevant outcome of proximal bowel clearance is considered, PEG-based regimens offer the most effective option.
之前对结肠镜检查肠道准备的综述得出了相互矛盾的结论。
采用符合 PRISMA 原则的方法提供明确的见解。
全面的文献综述确定了比较肠道准备方案的随机对照试验。使用多种纳入标准进行的多项荟萃分析汇总了肠道准备质量的数据。
共确定了 104 项符合条件的研究,其中大多数涉及比较磷酸钠(NaP)或聚乙二醇(PEG)。总体而言,NaP 和 PEG 之间没有显示出显著差异(OR=0.82;95%CI=0.56-1.21;P=0.36)。累积荟萃分析表明,自 20 世纪 90 年代中期以来,这一结论在质量上一直相似,过去 10 年来没有明显的数量变化。在研究组中都采用前一天剂量的研究中,PEG 有显著优势(OR=1.78;95%CI=1.13-2.81;P=0.006)。专注于近端结肠结果的研究也倾向于 PEG(OR=2.36;95%CI=1.16-4.77;P=0.012)。PEG 也明显比非 NaP 肠道准备方案更有效(OR=2.02;95%CI=1.08-3.78;P=0.03)。其他比较显示方案之间没有显著差异。
尽管没有令人信服的证据支持两种最常用的肠道准备方案中的任何一种,但这可能反映了研究设计的缺陷。在确保剂量相当或考虑近端肠道清除的临床相关结果的情况下,基于 PEG 的方案提供了最有效的选择。